| Price | $0.175 on 29-05-2025 at 18:30:06 |
|---|---|
| Change | $-0.004 -2.23% |
| Buy | $0.20 |
| Sell | $0.15 |
| Buy / Sell CRV Shares | |
| Last Trade: | Unknown 10.00 at $0.191548 |
| Day's Volume: | 110 |
| Last Close: | $0.175 |
| Open: | $0.18 |
| ISIN: | GB00BD4FQ360 |
| Day's Range | $0.175 - $0.18 |
| 52wk Range: | $0.15 - $0.45 |
| Market Capitalisation: | $676k |
| VWAP: | $0.18105 |
| Shares in Issue: | 4m |
Sector: Brokerage Services
Listed In: FTSE AIM All-Share,
Craven House Capital (CRV) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 10 | $0.191548 | Currency Conversion Negotiated Trade |
15:13:02 - 29-May-25 |
| Sell* | 7,500 | $0.15 | Ordinary |
16:35:29 - 28-May-25 |
| Buy* | 7,400 | $0.179 | Suspected BUY Trade |
16:35:19 - 28-May-25 |
| Sell* | 350 | $0.15 | Ordinary |
14:36:57 - 28-May-25 |
| Unknown* | 958 | $0.150287 | Ordinary Currency Conversion |
12:24:19 - 27-May-25 |
| Unknown* | 1,204 | $0.192627 | Currency Conversion Negotiated Trade |
12:00:17 - 27-May-25 |
| Buy* | 463 | $0.19 | Ordinary |
11:07:04 - 27-May-25 |
| Buy* | 239 | $0.20 | Ordinary |
08:21:34 - 27-May-25 |
| Unknown* | 77 | $0.192471 | Currency Conversion Negotiated Trade |
08:00:34 - 27-May-25 |
| Buy* | 180 | $0.20 | Ordinary |
11:39:02 - 23-May-25 |
Craven House Capital (CRV) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Feb 2025 7:00 am | RNS | Interim Results |
| 7th Feb 2025 4:22 pm | RNS | TR-1: Notification of major holdings |
| 16th Dec 2024 2:42 pm | RNS | Result of AGM |
| 15th Nov 2024 7:00 am | RNS | Annual Results For Year Ended 31 May 2024 |
| 10th Sep 2024 7:00 am | RNS | Investee company update: RoseMonkey Ltd |
| 27th Aug 2024 7:00 am | RNS | TR-1: Notification of major holdings |
| 23rd Aug 2024 2:19 pm | RNS | TR-1: notification of major holdings |
| 5th Jun 2024 7:00 am | RNS | Investee Companies' Update: Bio Vitos |
| 28th Feb 2024 7:00 am | RNS | Interim Results |
| 4th Jan 2024 7:00 am | RNS | Result of Annual General Meeting |
